XXI National Meeting of the Spanish Society of Medicinal Chemistry

Scientific Program


SUNDAY, JUNE 15th

16:00-17:30

Registration - Rectorado (US)

17:30-18:00

Inauguration

18:00-19:00

Opening Conference
Chairperson: Juan Carlos Morales
Speaker: Gunda Georg. University of Minnesota, USA: DISCOVERY AND DEVELOPMENT OF A MALE PILL BY TARGETING THE RETINOID SIGNALING PATHWAY WITH YCT-529 FOR EFFECTIVE, REVERSIBLE ORAL CONTRACEPTION

19:15-19:45

SEQT Awards

20:00

Welcome cocktail - Antigua Fábrica de Tabacos, Rectorado US

 

MONDAY, JUNE 16th

08:00-12:00

Registration - cicCartuja

Session 1

Chairperson: Beatriz de Pascual-Teresa
Co-Chair: Laureano E. Carpio Mulas
09:00-09:45 PL-02    Antonio Pineda. CIMA Navarra, Spain: PRECISION TOOLS IN IMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCIES: ADVANCES IN CAR-T CELL THERAPIES AND SYNTHETIC SINGLE-DOMAIN ANTIBODY DEVELOPMENT
09:45-10:15 KN-01    Tilly Bingham. Cumulus Oncology, UK: CASE STUDIES IN MEDICINAL CHEMISTRY: THE DISCOVERY OF WEE1 AND BRPF1 INHIBITORS
10:15-10:45 KN-02 Rebeca Deprez. University of Lille, France: FIRST SELECTIVE NANOMOLAR INHIBITORS OF ERAP2 IN AUTOIMMUNE DISEASES
10:45-11:00 OC-01    Robert J. Doerksen. University of Mississippi, US: PREDICTED SMALL MOLECULE FMLH INHIBITORS OF UROPATHOGENIC ESCHERICHIA COLI-INDUCED ADHESION TO TREAT URINARY TRACT INFECTIONS
11:00-11:15 OC-02    Carles Galdeano. University of Barcelona, Spain: A FIRST-IN-CLASS TET2 ACTIVATOR AS A NEW THERAPEUTIC STRATEGY AGAINST CANCER

11:15-11:45

Coffee break

Session 2

Chairperson: Marta Gutiérrez
11:45-12:15 KN-03    Francisco Corzana. University of La Rioja, Spain: STRUCTURE-GUIDED DESIGN OF GLYCOPEPTIDES FOR CANCER DIAGNOSIS AND THERAPY
12:15-12:45 KN-04    Salome Pinho. University of Porto, Portugal: GLYCANS AS REGULATORS OF IMMUNE RESPONSE IN INFLAMMATION, AUTOIMMUNITY AND CANCER: FROM DISEASE PREDICTION TO THERAPEUTIC OPPORTUNITIES
12:45-13:00 OC-03    Amparo Navarro. University of Jaén, Spain: MULTIPLE PATHWAYS FOR LANTHANIDE SENSITIZATION IN SELF-ASSEMBLED AQUEOUS SOLUTION FOR BIOIMAGING 
13:00-13-15 OC-04    Meriem Chayah. University of Granada, Spain: DEVELOPMENT OF INHIBITORS OF THE HA-CD44 INTERACTION AS A NEW STRATEGY FOR CANCER TREATMENT
13:15-13:20 FC-01    Maria Cremonini. University of Parma, ItalyTARGETING TELOMERIC G-QUADRUPLEXES WITH CATIONIC CALIXARENES
13:20-13:25 FC-02    Laura Gallego. University of Salamanca, Spain: INDOL DERIVATIVE COLCHICINE SITE LIGANDS: PROMISING ANTIMITOTICS AGAINST RESISTANT CANCER CELLS
13:25-13:30 FC-03    Eva Serrano. Centro Europeo de Empresas e Innovación (CEEI): TARGETING KIT-DRIVEN DISEASES: ML329 AS A PROMISING MITF PATHWAY INHIBITOR

13:30-15:15

Lunch & Monday Poster Session

Session 3

Chairperson: Eddy Sotelo
15:15-15:45 KN-05    María Méndez Pérez. Sanofi, Germany: DISCOVERY AND OPTIMIZATION OF A NEW CLASS OF RIPK1 INHIBITORS ENABLED BY LATE-STAGE PHOTOREDOX CATALYSIS
15:45-16:15 KN-06    Carolina Alhambra. Eli Lilly, Spain: ADVANCEMENTS IN AUTOMATED SYNTHESIS: THE ROLE OF AI IN DRUG DEVELOPMENT
16:15-16:30 OC-05    Juan Carlos Muñoz. Institute for Chemical Research, CSIC, Spain: A NEW NMR APPROACH ASSISTED BY MACHINE LEARNING TO ACCELERATE FRAGMENT SCORING
16:30-16:45 OC-06    Ana Mallo. University of Barcelona, Spain: LEAD OPTIMIZATION OF NOVEL PROTEIN AGGREGATION INHIBITORS WITH NANOMOLAR ANTIPLASMODIAL POTENCIES AND FAVORABLE DMPK PROPERTIES
16:45-17:00 OC-07    Rubén Prieto. University of Santiago de Compostela, Spain: DECIPHERING ALLOSTERIC MODULATION AT DOPAMINE D2 RECEPTORS: FUNCTIONAL AND STRUCTURAL INSIGHTS FROM MELANOSTATIN-INSPIRED LIGANDS
17:00-17:15 OC-08    Ouldouz Ghashghaei. University of Barcelona & IBUB, Barcelona, Spain: FIRST-IN-CLASS TREX2 INHIBITORS: A BREAKTHROUGH KERATINOCYTE-TARGETED THERAPY FOR PSORIASIS
17:15-17:20 FC-04    Daniel Cabrera. IQM-CSIC, Spain: DISCOVERY OF PAN-CORONAVIRUS ANTIVIRALS WITH A NOVEL MECHANISM OF ACTION
17:20-17:25 FC-05    David Rinaldo. Schrödinger GmbH, Germany: EXPLORING LARGE CHEMICAL SPACES FOR LEAD OPTIMIZATION
17:25-17:30 FC-06    Vanesa Nozal. University of Antwerp, BelgiumPOTENT DIPEPTIDYL PEPTIDASE 8/9 INHIBITORS DESIGNED VIA RELATIVE BINDING FREE ENERGY CALCULATIONS

17:30-18:30

DEMOS/Comm Activities/Free time

18:30-20:00

Networking time

 

TUESDAY, JUNE 17th

Session 4

Chairperson: Diego Muñoz Torrero
Co-Chair: Vanesa Nozal García
09:00-09:45 PL-03    Maria Laura Bolognesi. University of Bologna, Italy: (Molecules Plenary Lecture): UNLOCKING TARGETED PROTEIN DEGRADATION FOR NEGLECTED TROPICAL DISEASES
09:45-10:15 KN-07   Valle Palomo. IMDEA Nanoscience, Spain: QUANTUM DOTS AND PEPTIDE-BASED PROBES FOR THE UNDERSTANDING OF NEURODEGENERATIVE DISEASES
10:15-10:45 KN-08    Christophe Dardonville. IQM–CSIC, Spain: TRYPANOSOME ALTERNATIVE OXIDASE INHIBITORS WITH BROAD-SPECTRUM ACTIVITY AGAINST AFRICAN ANIMAL TRYPANOSOMES: FROM ORTHOSTERIC TO ALLOSTERIC INHIBITION
10:45-11:00 OC-09    Sonsoles Rodriguez. CNIO, Spain: TARGETED DEGRADATION OF MASTL KINASE
11:00-11:15 OC-10    Sergio Alvar Alonso. Johnson & Johnson, Spain: DISCOVERY OF NOVEL MGLUR2 NAMS. FROM HIT IDENTIFICATION TO IN-VIVO ACTIVITY IN RODENT'S COGNITION MODEL

11:15-11:45

Coffee break

Session 5

Chairperson: María Jesús Pérez Pérez
11:45-12:15 KN-09     María Marco. GSK, Spain: COMBINATION THERAPY FOR CHAGAS DISEASE – PYRROLOPYRIMIDINE SERIES
12:15-12:45 KN-10    Nathaniel Martin. University of Leiden, Netherlands IMPROVING NATURE’S ANTIBIOTICS THROUGH (SEMI)SYNTHESIS
12:45-13:00 OC-11    Eva Maria Priego. IQM-CSIC, SpainALLOSTERIC INHIBITION OF THE HOST NSMASE-2 AS A NOVEL APPROACH TOWARDS ANTIVIRALS AGAINST FLAVIVIRUSES
13:00-13-15 OC-12    Ignacio Pérez Victoria. Fundación MEDINA, Spain: MEDINAMYCIN, FIRST MEMBER OF A NEW STRUCTURAL CLASS WITHIN THE PHOSPHOGLYCOLIPID ANTIBIOTICS

13:30-15:15

Lunch & Tuesday Poster Session (P2XX to P2XX)

Session 6

Chairperson: Inmaculada Fernández
15:15-15:45 KN-11    Isabel Rozas. Trinity College Dublin, Ireland: PUT A GUANIDINIUM IN YOUR LIFE (OR HOW WONDERFUL IS THE GUANIDINIUM CATION FOR DIFFERENT APPLICATIONS!)
15:45-16:15 KN-12    Juan José Nogueira. Autonomous University of Madrid, Spain: COMPUTATIONAL INSIGHTS INTO BIOLOGICAL PROCESSES
16:15-16:30 OC-13    Carmen Pérez Alonso. Institute for Chemical Research, CSIC, Spain: EXPLORING FLUORINATED MAN5 GLYCOMIMETICS AS POTENTIAL INHIBITORS OF SARS-COV-2 VIRUS INFECTION
16:30-16:45 OC-14    Nazaret Moreno. University of Seville, Spain: TARGETING HEMATOLOGICAL CANCERS: SYNTHESIS AND EVALUATION OF NOVEL BENZOTHIAZOLE-BASED PPAR ANTAGONISTS

16:45-17:15

Coffee break

Session 7

Chairperson: Ana Conejo

17:15-17:45 KN-13    Noureddine Khiar. Institute for Chemical Research, CSIC, Spain: SUGARS MEET SULFUR: FROM SMALL MOLECULES TO FUNCTIONAL GLYCO-NANOMATERIALS / QUIMIOTECA CSIC (QCSIC)
17:45-17:50 FC-07    Leire Gaviria. University of Navarra, Spain: ORGANOSELENIUM IMINES: THEIR DUAL ROLE IN TREATING BACTERIAL INFECTIONS AND ALZHEIMER'S DISEASE
17:50-17:55 FC-08    Victor Fernández. IQM-CSIC, Spain: EXTENSIVE SAR STUDY LEADS TO THE DISCOVERY OF NANOMOLAR-POTENT LEISHMANICIDAL AGENTS
17:55-18:00 FC-09    Iván RivillaUniversity of the Basque Country, Spain: NOVEL PLATINUM-BASED CHEMOTHERAPEUTIC AGENTS AGAINST CHOLANGIOCARCINOMA BASED ON THE INDUCTION OF INTER-STRAND DNA BREAKS
18:00-18:05 FC-10    Carolina Miranda. University of Salamanca, SpainNEW HYBRID COMPOUNDS DERIVED FROM NATURAL PRODUCT PODOPHYLLOTOXIN TARGETING CANCER WITH DUAL MECHANISM OF ACTION
18:15-19:15 Asamblea General de la SEQT

21:00

Gala Dinner

 

WEDNESDAY, JUNE 18th

Session 8

Chairperson: Joaquin Calixto García
Co-Chair: Anna Sampietro Pifarre
09:30-10:00 KN-14    Carmen Ortiz. University of Seville, Spain: STRUCTURE-, VALENCY-, AND STIMULI-RESPONSIVE GLYCOMIMETICS IN BIOLOGY AND MEDICINE: TARGETING ENZYMES, LECTINS, AND IMMUNE MEDIATORS
10:00-10:30 KN-15    Concepción Alonso. University of the Basque Country, Spain: DESIGN AND BIOLOGICAL EVALUATION OF NEW HETEROCYCLIC FAMILIES OF TOPOISOMERASE I INHIBITORS WITH ANTIPROLIFERATIVE POTENTIAL
10:30-10:45 OC-15    Irene Ortín. University San Pablo-CEU, Madrid, Spain: FOLATES CONJUGATES: A BREAKTHROUGH IN THE FIGHT AGAINST CANCER
10:45-11:00 OC-16    Victoria Mora. EU-OPENSCREEN ERIC, Germany EU-OPENSCREEN – AN OPEN ACCESS INITIATIVE TO IDENTIFY NEW BIOLOGICAL ACTIVITIES OF YOUR COMPOUNDS
11:00-11:05 FC11    Ana Alcudia. University of Seville, Spain: IMPLANTS THAT WORK SMARTER: THE ROLE OF BIOFUNCTIONAL COATINGS IN ADVANCING HEALTHCARE
11:05-11:10 FC-12    Daniel Fernández. Complutense University of Madrid, Spain: DISCOVERY OF NOVEL PROGERIN LIGANDS FOR PROTAC-BASED PROGERIA TREATMENT
11:10-11:15 FC-13    Javier Sánchez. University of Barcelona, SpainDUAL-MECHANISM PAIN MODULATION: SIGMA-1 ANTAGONISM AND SEH INHIBITION FOR ENHANCED ANALGESIA

11:15-11:45

Coffee break

Session 9

Chairperson: José Manuel Bartolomé
11:45-12:15 KN-16    Teresa de Haro. UCB, Belgium:  INHIBITION OF PLASMEPSIN X: A PROMISING STRATEGY AGAINST MALARIA
12:15-12:45 KN-17    Juan Miguel Jimenez. Johnson & Johnson, Belgium: NEW DIRECTIONS IN DRUG DISCOVERY: EXPANDING EXPLORATION OF CHEMICAL SPACE
12:45-12:50 FC-14    Premio ALMIRALL. Andrea Bertran Mostazo. University of Barcelona, Spain: INDUCING TARGETED PROTEIN DEGRADATION BY ALLOSTERIC MODULATION OF THE FBW7 E3 LIGASE
12:50-12:55 FC-15    Premio Johnson & Johnson. Marta Durán Martínez. University of Alcalá, Spain: BÚSQUEDA DE NUEVAS MOLÉCULAS PEQUEÑAS ACTIVADORAS DE LA QUINASA LIGADA A INTEGRINAS
12:55-13:00 FC-16    Premio LILLY. Anabel Sánchez Merino. Complutense University of Madrid, Spain: DEVELOPMENT OF NEW MICROBIOTA-INSPIRED COMPOUNDS FOR THE VALIDATION OF NPM1 PROTEIN AS A THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA
13:00-13:05 FC-17    Premio MENARINI. Miguel Marín Folgado. University of Salamanca, Spain: NEW TUBULIN-INHIBITING ANTITUMOR AGENTS WITH DIARYLTETRAZOLE STRUCTURE: DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION
13:05-13:20 OC-17    Premio SEQT Article. Diego García Jiménez. University of Torino, Italy: MOLECULAR CHAMELEONICITY: NOVEL STRATEGIES IN THE BRo5 SPACE
13:20-13:35 OC-18    Premio «RAMON MADROÑERO» de la S.E.Q.T. Álvaro de la Cruz Potenciano. IQM-CSIC, Spain: ATTACKING THE ACHILLES' HEEL OF THE INFLUENZA VIRUS: INHIBITORS OF VIRAL HEMAGGLUTININ FUSION INHIBIDORES DE FUSIÓN DE LA HEMAGLUTININA VIRAL

13:45

Best Communications ChemMedChem and ChemBioChem Awards & Closing Ceremony.